Engineers have developed a lipid nanoparticle (LNP ... developing this cure for pre-eclampsia and getting it to the market for human use is on the horizon for the research team, Swingle had ...

In previous research, Swingle conducted a successful proof-of-concept study that examined a library of lipid nanoparticles ... eclampsia and getting it to the market for human use is on the ...

In previous research, Swingle conducted a successful proof-of-concept study that examined a library of lipid nanoparticles ... eclampsia and getting it to the market for human use is on the ...

The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...

Generation Bio (GBIO) announced it is leveraging its validated T cell-directed lipid nanoparticle to develop siRNA therapeutics to silence ...

Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...

Function-engineerable nanoparticles in combination with the advantageous effects of various functional lipid components enable achievement of enhanced blood stability, decreased toxicity and ...

Generation Bio ( (GBIO) ) has issued an announcement.

Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm's expertise in customized nucleic ...